Catheter Precision, Inc. (NYSEAMERICAN:VTAK) Sees Significant Decline in Short Interest

Catheter Precision, Inc. (NYSEAMERICAN:VTAK) was the target of a large decline in short interest in November. As of November 15th, there was short interest totalling 87,300 shares, a decline of 52.5% from the October 31st total of 183,700 shares. Based on an average trading volume of 3,550,000 shares, the short-interest ratio is currently 0.0 days. Approximately 1.2% of the shares of the stock are short sold.

Catheter Precision Stock Performance

Shares of NYSEAMERICAN:VTAK opened at $0.42 on Thursday. The company has a debt-to-equity ratio of 0.12, a current ratio of 0.66 and a quick ratio of 0.65. Catheter Precision has a fifty-two week low of $0.31 and a fifty-two week high of $8.40.

About Catheter Precision

Catheter Precision, Inc designs, manufactures, and sells medical technologies for the field of cardiac electrophysiology (EP) in the United States. The company’s lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures.